FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer December 18, 2020 Auto Bot News 0 Today, the FDA approved the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.